Pharmacokinetics and bioavailability of the isoflavone biochanin A in rats
β Scribed by Young Jin Moon; Kazuko Sagawa; Kosea Frederick; Shuzhong Zhang; Marilyn E. Morris
- Book ID
- 119986613
- Publisher
- American Association of Pharmaceutical Scientists
- Year
- 2006
- Tongue
- English
- Weight
- 291 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1550-7416
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract There are limited reports on the bioavailability and pharmacokinetics of isoflavones in elderly humans and aged animals. The present study was conducted to assess the effect of glycosidation of isoflavones on their bioavailability and pharmacokinetics in aged (20 month old) male Fischer
Effects of coadministration of dietary supplement biochanin A (BA) on the pharmacokinetics of three P-glycoprotein substrates, paclitaxel, digoxin, and fexofenadine, were investigated in rats. With BA coadministration, the oral bioavailability and peak plasma concentration were markedly increased by
In a pharmacokinetic study, 15, 30, 60, and 150 mg kg-' intravenous and oral doses of methocarbamol were administered to rats. Differences observed in plasma clearance values, i.e. 0~0203,0~0156,0~0123, and 0-0085 1 kg-' min-' for 15,30,60, and 150 mg kg-', respectively, suggested a dosedependent ph
## Abstract Isoflavones containing foods and dietary supplements are widely consumed for putative health benefits (__e.g__. cancer chemoprevention, beneficial effects on serum lipids associated with cardiovascular health, reduction of osteoporosis, relief of menopausal symptoms). This paper describ